GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,766,000 | -32.4% | 63,500 | -42.9% | 0.01% | -25.0% |
| Q4 2020 | $4,091,000 | -60.6% | 111,180 | -59.7% | 0.01% | -68.0% |
| Q3 2020 | $10,386,000 | +31.5% | 275,934 | +42.5% | 0.02% | -7.4% |
| Q2 2020 | $7,897,000 | +1635.6% | 193,600 | +1513.3% | 0.03% | +800.0% |
| Q1 2020 | $455,000 | -93.0% | 12,000 | -91.3% | 0.00% | -90.9% |
| Q4 2019 | $6,489,000 | -49.1% | 138,100 | -53.8% | 0.03% | -58.8% |
| Q3 2019 | $12,744,000 | +16.2% | 298,600 | +8.9% | 0.08% | +9.6% |
| Q2 2019 | $10,969,000 | -23.0% | 274,100 | -19.6% | 0.07% | -12.0% |
| Q1 2019 | $14,242,000 | -42.7% | 340,800 | -47.6% | 0.08% | -47.5% |
| Q4 2018 | $24,870,000 | -3.4% | 650,881 | +1.5% | 0.16% | +39.8% |
| Q3 2018 | $25,757,000 | – | 641,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |